What is ClearFlow?
ClearFlow is dedicated to advancing cardiac surgery through its innovative medical technologies. Their core offerings include the PleuraFlow Active Clearance Technology and ClearFix Rigid Sternal Fixation, both designed to enhance patient recovery and mitigate risks such as Retained Blood Syndrome. The company primarily serves healthcare institutions focused on cardiac care, aiming to optimize resource utilization and accelerate patient recovery times. ClearFlow's commitment extends to supporting medical professionals through education and robust assistance, thereby fostering the adoption of improved surgical practices.
How much funding has ClearFlow raised?
ClearFlow has raised a total of $21.8M across 8 funding rounds:
Private Equity
$1.2M
Private Equity
$4.9M
Private Equity
$4.2M
Debt
$2.8M
Private Equity
$5.5M
Debt
$350K
Debt
$2.1M
Private Equity (2010): $1.2M, investors not publicly disclosed
Private Equity (2011): $4.9M, investors not publicly disclosed
Private Equity (2013): $4.2M, investors not publicly disclosed
Debt (2014): $2.8M, investors not publicly disclosed
Private Equity (2015): $5.5M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Debt (2025): $2.1M, investors not publicly disclosed
Key Investors in ClearFlow
PPP
Public-Private Partnership
What's next for ClearFlow?
With the recent major strategic investment, ClearFlow is poised for significant expansion and further product development. The substantial capital infusion, alongside the overall $21.8M raised, suggests the company is entering a growth phase, likely focusing on scaling manufacturing, broadening market penetration, and potentially investing in research and development for next-generation medical devices. This strategic backing will enable ClearFlow to further solidify its position in the competitive medical technology landscape and enhance its impact on patient care in cardiac surgery.
See full ClearFlow company page
